← Back to Clinical Trials
RecruitingNCT07044596

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionMild Traumatic Brain Injury
SponsorUniversity of Wisconsin, Madison
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment55
SexALL
Min Age20 Years
Max Age85 Years
Start Date2025-11-13
Completion2026-08
Interventions
Functional near-infrared spectroscopy (fNIRS)V1 stimulation electrodesMagnetic Resonance Imaging (MRI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in the brain and prevent build up that may lead to disease.

Eligibility Criteria

Inclusion Criteria - Healthy Participants : * Age 20-85 years * Willing and able to undergo all procedures * Free of any neurological (e.g., epilepsy, stroke, Parkinson's, brain tumors, moderate or severe traumatic brain injury), neuropsychiatric (e.g., schizophrenia, substance abuse, clinical depression), or developmental (e.g., autism, ADHD) or any other medical condition at the discretion of the PI and co-investigators Inclusion Criteria - mTBI : * Age 20-65 * Diagnosed with mild traumatic brain injury and be within 1-52 weeks post-injury * Willing and able to undergo all procedures Exclusion Criteria - Healthy Participants: * Contraindication to MRI * Known allergies to common electrode materials Exclusion Criteria - mTBI: * Contraindications for MRI * Known allergies to common electrode materials * Candidates currently on cardiovascular medications which, in the opinion of the investigators, would introduce a confounding factor to glymphatic system function (i.e. ACE-inhibitors, a

Related Trials